Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)

PHASE3CompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

November 30, 2014

Conditions
Peri-Implantitis
Interventions
DRUG

Minocycline HCl Microspheres

Trial Locations (10)

19104

University of Pennsylvania School of Dental Medicine, Philadelphia

21201

University of Maryland, School of Dentistry, Baltimore

27599

University of North Carolina at Chapel Hill School of Dentistry, Chapel Hill

29403

Medical University of South Carolina College of Dental Medicine, Charleston

38163

UTHSC - College of Dentistry, Memphis

48106

University of Michigan - Michigan Center for Oral Health Research, Ann Arbor

53233

Marquette University School of Dentstry, Milwaukee

64108

University of Missouri - Kansas City School of Dentistry Clinical Research Center, Kansas City

98056

Virginia Commonwealth University School of Dentistry, Richmond

02111

Tufts University School of Dental Medicine, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

OraPharma

INDUSTRY

NCT01517334 - Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation) | Biotech Hunter | Biotech Hunter